{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=45", "query": { "intervention": "Biological Control", "page": 45 }, "page_size": 10 }, "pagination": { "page": 45, "page_size": 10, "total_count": 1573, "total_pages": 158, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=46&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=44&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T14:39:31.818Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00998738", "title": "Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neuropathy", "Pain", "Recurrent Breast Carcinoma", "Stage IV Breast Cancer" ], "interventions": [ { "name": "Calcium Gluconate", "type": "DRUG" }, { "name": "Magnesium Sulfate", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Ixabepilone", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2009-11", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2016-02-04", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00998738" }, { "nct_id": "NCT05444465", "title": "Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rotator Cuff Injuries" ], "interventions": [ { "name": "Isolated Bioinductive Repair", "type": "DEVICE" }, { "name": "Completion and Repair", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Smith & Nephew, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 234, "start_date": "2022-08-30", "completion_date": "2029-02-28", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 8, "location_summary": "Rome, Georgia • Rockford, Illinois • Baltimore, Maryland + 5 more", "locations": [ { "city": "Rome", "state": "Georgia" }, { "city": "Rockford", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Garfield Heights", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05444465" }, { "nct_id": "NCT04083833", "title": "A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "TQT Study" ], "interventions": [ { "name": "Tetrodotoxin", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wex Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 25, "start_date": "2018-02-07", "completion_date": "2018-03-24", "has_results": false, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04083833" }, { "nct_id": "NCT04919499", "title": "A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetic Retinopathy" ], "interventions": [ { "name": "BI 765128", "type": "DRUG" }, { "name": "Sham comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-07-30", "completion_date": "2023-08-07", "has_results": true, "last_update_posted_date": "2024-11-21", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 11, "location_summary": "Bakersfield, California • Sacramento, California • Walnut Creek, California + 7 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04919499" }, { "nct_id": "NCT02465463", "title": "Early FMT for C.Difficile", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Clostridium Difficile" ], "interventions": [ { "name": "Fecal microbiota transplant (FMT)", "type": "PROCEDURE" }, { "name": "flexible sigmoidoscopy", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DEVICE" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 13, "start_date": "2015-06", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2018-01-31", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02465463" }, { "nct_id": "NCT00404664", "title": "Improving Influenza Vaccination Rates Among Health Care Professionals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "influenza vaccine, reminders letters, raffle prize", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 800, "start_date": "2004-09", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2006-11-29", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00404664" }, { "nct_id": "NCT05322252", "title": "Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Abortion, Second Trimester", "PPROM", "Rupture, Spontaneous", "Fetal Demise", "Fetal Death", "Fetal Demise From Miscarriage", "Fetal Death Before 22 Weeks With Retention of Dead Fetus", "Pregnancy Loss", "Pregnancy Complications" ], "interventions": [ { "name": "Mifepristone", "type": "DRUG" }, { "name": "Misoprostol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2022-07-01", "completion_date": "2025-07-14", "has_results": true, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05322252" }, { "nct_id": "NCT01474135", "title": "AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "0.25% AR-12286 / 0.004% travoprost", "type": "DRUG" }, { "name": "0.5% AR-12286, 0.004% travoprost", "type": "DRUG" }, { "name": "0.004% Travoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 93, "start_date": "2011-12", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 9, "location_summary": "Inglewood, California • Newport Beach, California • Petaluma, California + 6 more", "locations": [ { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01474135" }, { "nct_id": "NCT03250338", "title": "Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations" ], "interventions": [ { "name": "Crenolanib", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Mitoxantrone", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Idarubicin", "type": "DRUG" }, { "name": "G-CSF", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arog Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 106, "start_date": "2018-08-16", "completion_date": "2026-04-03", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 9, "location_summary": "Sacramento, California • Gainesville, Florida • Chicago, Illinois + 4 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03250338" }, { "nct_id": "NCT01627340", "title": "Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis B" ], "interventions": [ { "name": "Engerix™-B vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": null, "sex": "ALL", "summary": "20 Years and older" }, "enrollment_count": 667, "start_date": "2012-07-24", "completion_date": "2013-12-18", "has_results": true, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-10-31T14:39:31.818Z", "location_count": 10, "location_summary": "Huntsville, Alabama • Stockbridge, Georgia • Boise, Idaho + 7 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Boise", "state": "Idaho" }, { "city": "Mishawaka", "state": "Indiana" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01627340" } ] }